Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
lung cancer treatment
Dec 5, 2023, 19:09 |
Blog
Narjust Florez: Ready for a Pregnancy and Lung Cancer Tweetorial?
Narjust Florez shared a post on her X/Twitter page: "Ready for a Pregnancy and Lung…
Dec 5, 2023, 18:57 |
Blog
Yvonne Diaz: Had the pleasure of interviewing Kizz, fellow ALK+ lung cancer patient
Yvonne Diaz, Director of Global Media Relations and Social Media at EY, shared on X/Twitter:…
Dec 1, 2023, 22:33 |
Blog
Jose Vicente Cardona: Here are nine recent developments in the fight against cancer
Jose Vicente Cardona, Group Director Oncology, Global Medical Affairs at Roche, made the following post…
Nov 27, 2023, 17:17 |
Insight
Vivek Subbiah: Treatment patterns and overall survival (OS) in patients with advanced NSCLC in three countries between 2011 and 2020
Vivek Subbiah shared on LinkedIn: “Pleased to share our paper in American Cancer Society journal…
Nov 14, 2023, 18:44 |
Blog
Jason Sheltzer: Tumors from Black cancer patients exhibit an increased frequency of whole-genome duplication events
Jason Sheltzer, Assistant professor at Yale School of Medicine, shared a post by medRxiv on…
Nov 7, 2023, 03:01 |
Blog
Rasha Aboelhassan: 14th preceptorship Lung prime IEO
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared on LinkedIn: "When it comes to…
Nov 6, 2023, 03:56 |
Blog
Christine Lovly: Kicking off lung cancer awareness month with a special shout out to the amazing lung community
Christine Lovly shared a post on X/Twitter: "Kicking off lung cancer awareness month with a special…
Oct 18, 2023, 16:43 |
Drugs
U.S. FDA approved pembrolizumab for NSCLC as single-agent for adjuvant and in combination with chemo for neoadjuvant settings - American Association for Cancer Research
American Association for Cancer Research recently shared on its Twitter page: "Today, the U.S. FDA…
Oct 15, 2023, 17:54 |
Insight
Balazs Halmos: 4.1% annual drop in lung cancer deaths! If we keep this pace (or speed up) - can u imagine what might happen?
Balazs Halmos, Associate Director for Clinical Science at Montefiore Einstein Cancer Center, shared a post…
Oct 13, 2023, 17:10 |
Drugs
Rami Manochakian: FDA Oncology approves the combination of Encorafenib and Binimetinib for Patients with metastatic Non-Small cell Lung Cancer with a BRAF V600E mutation.
35
36
37
38
39
All:
851
Posts:
361 - 370
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube